Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122425) titled 'A randomized controlled study on the use of tegileridine for postoperative analgesia in patients undergoing laparoscopic colorectal tumor surgery' on April 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Sun Yat-Sen University
Condition:
post-operative pain
Intervention:
Tegileridine Group (Group T):Single intravenous dose of 1 mg administered via slow pump infusion over 10 minutes
30 minutes after the start of the initial dose, a Patient-Controlled Analgesia (PCA) dose of 0.1 mg is available.
Hydromorphone Group (Group M):Single intravenous do...